background
Jill Durocher

Mifepristone's Multiple RH Indications: An overlooked Opportunity for Expanding Access

Published
September 23rd, 2019
Type
Program Brief
Topic
Medical Abortion
Authors
Gynuity Health Projects
Downloads

Gynuity Health Projects, with a grant from the Innovation Fund of the Reproductive Health Supplies Coalition, assembled a brief with information regarding four reproductive health indications for mifepristone, beyond early medical abortion. This brief reviews the current evidence around Early Pregnancy Loss, Intrauterine Fetal Death, Cervical Preparation, and Second Trimester Abortion. These additional indications for mifepristone may provide an avenue for registration of the drug in places where early medical abortion is limited.